Overview of Dr. Samuel
Dr. Michael Samuel is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 8 years. He is one of 368 doctors at New York-Presbyterian Hospital and one of 115 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. He has more than 10 publications and over 500 citings.
Office
520 East 70th Street
Starr Pavilion, 3rd Floor
New York, NY 10021- Is this information wrong?
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2012 - 2015- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2009 - 2012
State University of New York Downstate Medical Center College of MedicineClass of 2009
Certifications & Licensure
NY State Medical License 2015 - 2026
Publications & Presentations
PubMed
- 2 citationsImmunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome.David C Helfgott, Sabrina Racine-Brzostek, Kelsey J Short, Zhen Zhao, Paul Christos, Itzel Nino, Tina Niu, Jorge Contreras, Ellen K Ritchie, Pinkal Desai, Michael Samu...> ;Leukemia & Lymphoma. 2023 Mar 1
- 2 citationsPhase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy.Sangmin Lee, Pinkal Desai, Bianca Edirisinghe, Tania J. Curcio, Michael Samuel, Ellen K. Ritchie, Gail J. Roboz, Samantha Pianello> ;Leukemia & Lymphoma. 2021 Jan 28
- 13 citationsSystemic Delivery of Anti-integrin αL Antibodies Reduces Early Macrophage Recruitment, Inflammation, and Scar Formation in Murine Burn WoundsXanthe L. Strudwick, Damian H. Adams, Natasha T. Pyne, Michael Samuel, Rachael Z. Murray, Allison J. Cowin> ;Advances in Wound Care. 2020 Oct 30
- Join now to see all
Abstracts/Posters
- CPX-351 As First Intensive Therapy for Elderly Patients with AMLMichael B. Samuel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Antecedent Clonal Hematopoesis and Risk of and Mortality after Solid and Hematological Malignancies: Analyses from the Women's Health Initiative StudyMichael B. Samuel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- PTPN11 Mutated Acute Myeloid Leukemia (AML) Features an Abundant Epichaperome Network and Is Sensitive to the Epichaperome Inhibitor PU-H71Michael B. Samuel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Hospital Affiliations
New York-Presbyterian HospitalNew York, New York- New York-Presbyterian HospitalNew York, New York
- New York-Presbyterian HospitalNew York, New York
NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
